A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
Jang A, Nakashima L, Ng T, Fung M, Jiwani S, Schaff K, Suess J, Goncalves R, Jang D, Kuik K, Labelle S, Pow A.
Jang A, et al. Among authors: suess j.
J Oncol Pharm Pract. 2021 Apr;27(3):635-643. doi: 10.1177/1078155220929756. Epub 2020 Jun 15.
J Oncol Pharm Pract. 2021.
PMID: 32539663
Clinical Trial.